查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1948361

2026年全球器官移植診斷市場報告

Transplant Diagnostics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，移植診斷市場發展迅速，預計將從2025年的20.7億美元成長到2026年的22.5億美元，複合年成長率達8.5%。過去幾年的成長可歸因於多種因素，例如器官移植手術數量的增加、組織配對技術的進步、免疫遺傳疾病盛行率的上升、移植中心的擴張以及政府對器官捐贈計畫的資助。

預計未來幾年，移植診斷市場將維持強勁成長，2030年市場規模將達到29.6億美元，複合年成長率（CAGR）為7.1%。預測期內的成長主要歸功於人工智慧和機器學習在檢測領域的應用、次世代定序（NGS）技術的普及、個人化免疫療法的擴展、雲端診斷篩檢的興起以及全球器官捐贈意識的不斷提高。預測期內的關鍵趨勢包括快速組織分型、人工智慧輔助的供受者配對、分子診斷技術的整合、高通量篩選技術以及雲端移植資料管理。

慢性病盛行率的不斷上升正在推動移植診斷市場的未來擴張。慢性病是指通常進展緩慢的長期健康狀況，例如糖尿病、心臟病和關節炎，這些疾病往往需要持續的醫療監測和生活方式的改變來控制症狀並避免併發症。慢性病的增加很大程度上與不健康的生活方式習慣有關，例如營養不良、缺乏運動和吸煙，這些都會增加心血管疾病、糖尿病和肥胖的風險。移植診斷在慢性病治療中發揮著至關重要的作用，它能夠準確監測器官功能並早期發現移植相關併發症。這些診斷工具透過支持及時的臨床決策、個人化的治療策略和提高器官的長期存活率來改善患者的預後。例如，根據英國政府機構國家醫療服務體系（NHS）的數據，截至2024年6月，在全科醫生（GP）註冊的患者中，有3,615,330人在2023年被診斷出患有非糖尿病性高血糖症，比2022年增加了18%。因此，慢性病盛行率的上升正在促進移植診斷技術的日益普及。

為了擴大在移植診斷市場的佔有率，主要企業正致力於推出先進的移植診斷服務。這些服務利用創新工具和技術，提高移植前後檢測的準確性和效率。例如，總部位於美國的醫療檢測公司Quest Diagnostics於2023年3月推出了“Quest高級專業移植服務”，提供超過170種專業的移植和傳染病檢查。這些服務包括：在電子健康記錄中分析檢測結果、提供24小時臨床諮詢支援、提供病患教育資料以及快速檢測服務（部分結果可在8至24小時內取得）。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球器官移植診斷市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 人工智慧（AI）和自主人工智慧
    • 生物技術、基因組學和精準醫學
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 物聯網、智慧基礎設施和互聯生態系統
  • 主要趨勢
    • 快速組織分型
    • 基於人工智慧的供受者匹配
    • 分子診斷整合
    • 高通量篩檢技術
    • 基於雲端的移植資料管理

第5章 終端用戶產業市場分析

  • 醫院
  • 移植中心
  • 研究所
  • 商業診斷服務提供者
  • 學術機構

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球器官移植診斷市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球器官移植診斷市場規模、比較及成長率分析
  • 全球器官移植診斷市場表現：規模與成長，2020-2025年
  • 全球器官移植診斷市場預測：規模與成長，2025-2030年，2035年預測

第8章 全球總潛在市場（TAM）

第9章 市場細分

  • 按類型
  • 試劑和耗材、設備、軟體和服務
  • 按移植類型
  • 固態器官，幹細胞
  • 管風琴
  • 腎臟、肝臟、心臟、肺臟、胰腺
  • 透過技術
  • 非分子檢測、分子檢測
  • 最終用戶
  • 醫院和移植中心、研究機構和移植中心、商業服務供應商
  • 按類型細分：試劑和耗材
  • PCR試劑、抗體和抗原、檢體採集試劑盒、對照材料
  • 按類型細分：設備
  • 流式細胞儀、PCR儀、定序儀、發光儀
  • 按類型細分：軟體和服務
  • 數據分析軟體、實驗室資訊管理系統（LIMS）、諮詢服務、技術支援與維護服務

第10章 區域與國家分析

  • 全球器官移植診斷市場：依地區、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測
  • 全球器官移植診斷市場：依國家、績效及預測分類，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 器官移植診斷市場：競爭格局與市場佔有率，2024 年
  • 器官移植診斷市場：公司估值矩陣
  • 器官移植診斷市場：公司概況
    • F. Hoffmann La-Roche AG
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories Inc.
    • Becton-Dickinson and Company
    • Hologic Inc.

第37章：其他領先和創新企業

  • Illumina Inc., BioMerieus SA, Biomerieux SA, Grafton Companies, Bio-Rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen NV, Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年器官移植診斷市場：提供新機會的國家
  • 2030年器官移植診斷市場：新興細分市場機會
  • 2030年器官移植診斷市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MTDIA03_G26Q1

Transplant diagnostics refer to tests performed before organ or tissue transplantation. They primarily focus on histocompatibility and immunogenetics to evaluate compatibility between donor and recipient, particularly in organ transplants and hematopoietic stem cell transplants.

The main product categories in the transplant diagnostics market include reagents and consumables, instruments, and software and services. Transplant diagnostic instruments are designed to enhance the speed and accuracy of transplant-related testing. The technologies include non-molecular assays and molecular assays used for transplantation of organs such as the kidney, liver, heart, lung, and pancreas. The transplant types include solid organ and stem cell transplants, and these solutions are used by end users such as hospitals and transplant centers, research laboratories, and commercial service providers.

Tariffs are impacting the transplant diagnostics market by increasing costs for imported reagents, molecular assay kits, and sequencing instruments. Hospitals and transplant centers in regions like North America and Europe are most impacted, particularly for high-end molecular assays. While cost pressures have slowed some procurement, tariffs have also encouraged local manufacturing of reagents and instruments, stimulating regional market growth and innovation.

The transplant diagnostics market research report is one of a series of new reports from The Business Research Company that provides transplant diagnostics market statistics, including transplant diagnostics industry global market size, regional shares, competitors with a transplant diagnostics market share, detailed transplant diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the transplant diagnostics industry. This transplant diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The transplant diagnostics market size has grown strongly in recent years. It will grow from $2.07 billion in 2025 to $2.25 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to rising organ transplantation procedures, advancements in histocompatibility testing, increasing prevalence of immunogenetic disorders, expansion of transplant centers, government funding for organ donation programs.

The transplant diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.96 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to integration of ai and machine learning in testing, adoption of next-generation sequencing (NGS), expansion of personalized immunotherapy, growth of cloud-based diagnostics platforms, increased global organ donation awareness. Major trends in the forecast period include rapid histocompatibility testing, ai-powered donor-recipient matching, molecular diagnostics integration, high-throughput screening techniques, cloud-based transplant data management.

The increasing prevalence of chronic diseases is increasingly supporting the expansion of the transplant diagnostics market going forward. Chronic diseases are long-lasting health conditions that usually progress slowly, including diabetes, heart disease, and arthritis, and often require continuous medical supervision and lifestyle modifications to manage symptoms and avoid complications. The rise in chronic diseases is largely associated with unhealthy lifestyle patterns, such as poor nutrition, lack of physical activity, and smoking, which heighten the risk of cardiovascular disease, diabetes, and obesity. Transplant diagnostics play an essential role in chronic disease care by enabling accurate monitoring of organ function and early identification of transplant-related complications. These diagnostic tools improve patient outcomes by supporting timely clinical decisions, personalized treatment strategies, and enhanced long-term organ survival. For example, in June 2024, according to the National Health Service, a UK-based government department, 3,615,330 individuals registered with a GP were identified with non-diabetic hyperglycemia in 2023, representing an 18% increase from 2022. As a result, the growing prevalence of chronic diseases is contributing to increased adoption of transplant diagnostics.

Leading companies operating in the transplant diagnostics market are focused on introducing advanced transplant diagnostic services to expand their market presence. Advanced transplant diagnostic services use novel tools and technologies to improve the accuracy and efficiency of pre- and post-transplant testing. For example, in March 2023, Quest Diagnostics, a US-based medical laboratory company, launched Quest Advanced Specialized Transplant Services, offering more than 170 specialized transplant and infectious disease tests. The service includes longitudinal test trend analysis in electronic medical records, 24-hour clinical consultation support, patient education materials, and expedited testing services, with some results available within 8 to 24 hours.

In October 2024, Werfen, S.A., a Spain-based supplier of specialized diagnostic instruments and reagents, acquired Omixon Biocomputing Ltd. for approximately $25 million. Through this acquisition, Werfen aims to strengthen and expand its transplant diagnostics portfolio in hospitals and clinical laboratories by incorporating Omixon's advanced next-generation sequencing and bioinformatics technologies. Omixon Biocomputing Ltd. is a Hungary-based molecular diagnostics company specializing in transplant diagnostic solutions.

Major companies operating in the transplant diagnostics market are F. Hoffmann La-Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Becton-Dickinson and Company, Hologic Inc., Illumina Inc., BioMerieus S.A, Biomerieux SA, Grafton Companies, Bio-rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV, Olerup SSp AB, Genome Diagnostics B.V., Transplant Genomics Inc., Omixon Ltd., BAG Healthcare GmbH, Histogenetics Inc., Linkage Biosciences lnc., Gendrive plc

North America was the largest region in the transplant diagnostics market in 2025. Western Europe was the second largest region in the transplant diagnostics market report. The regions covered in the transplant diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transplant diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The transplant diagnostics market includes revenues earned by entities by PCR-based molecular assays, sequencing-based molecular assays, and non-molecular assay technologies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transplant Diagnostics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses transplant diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transplant diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The transplant diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Reagent And Consumables; Instrument; Software And Services
  • 2) By Transplant Type: Solid Organ; Stem Cell
  • 3) By Organ: Kidney; Liver; Heart; Lung; Pancreas
  • 4) By Technology: Non Molecular Assay; Molecular Assay
  • 5) By End User: Hospitals And Transplant Centers; Research Laboratories AndTransplant Centers; Commercial Service Providers
  • Subsegments:
  • 1) By Reagent And Consumables: PCR Reagents; Antibodies And Antigens; Sample Collection Kits; Control Materials
  • 2) By Instrument: Flow Cytometers; PCR Machines; Sequencers; Luminometers
  • 3) By Software And Services: Data Analysis Software; Laboratory Information Management Systems (LIMS); Consulting Services; Technical Support And Maintenance Services
  • Companies Mentioned: F. Hoffmann La-Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories Inc.; Becton-Dickinson and Company; Hologic Inc.; Illumina Inc.; BioMerieus S.A; Biomerieux SA; Grafton Companies; Bio-rad Laboratories Inc.; Sigma-Aldrich Corporation; Qiagen N.V.; Immucor Transplant Diagnostics Inc.; Immucor Inc.; Luminex Corporation; Affymetrix Inc.; CareDx Company; One Lambda Inc.; Eurobio Scientific Group; Gendx BV; Olerup SSp AB; Genome Diagnostics B.V.; Transplant Genomics Inc.; Omixon Ltd.; BAG Healthcare GmbH; Histogenetics Inc.; Linkage Biosciences lnc.; Gendrive plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Transplant Diagnostics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Transplant Diagnostics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Transplant Diagnostics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Transplant Diagnostics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Artificial Intelligence & Autonomous Intelligence
    • 4.1.2 Biotechnology, Genomics & Precision Medicine
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rapid Histocompatibility Testing
    • 4.2.2 Ai-Powered Donor-Recipient Matching
    • 4.2.3 Molecular Diagnostics Integration
    • 4.2.4 High-Throughput Screening Techniques
    • 4.2.5 Cloud-Based Transplant Data Management

5. Transplant Diagnostics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Transplant Centers
  • 5.3 Research Laboratories
  • 5.4 Commercial Diagnostic Service Providers
  • 5.5 Academic Institutions

6. Transplant Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Transplant Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Transplant Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Transplant Diagnostics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Transplant Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Transplant Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Transplant Diagnostics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Transplant Diagnostics Market Segmentation

  • 9.1. Global Transplant Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Reagent And Consumables, Instrument, Software And Services
  • 9.2. Global Transplant Diagnostics Market, Segmentation By Transplant Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Solid Organ, Stem Cell
  • 9.3. Global Transplant Diagnostics Market, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Kidney, Liver, Heart, Lung, Pancreas
  • 9.4. Global Transplant Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Non Molecular Assay, Molecular Assay
  • 9.5. Global Transplant Diagnostics Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Transplant Centers, Research Laboratories And Transplant Centers, Commercial Service Providers
  • 9.6. Global Transplant Diagnostics Market, Sub-Segmentation Of Reagent And Consumables, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PCR Reagents, Antibodies And Antigens, Sample Collection Kits, Control Materials
  • 9.7. Global Transplant Diagnostics Market, Sub-Segmentation Of Instrument, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Flow Cytometers, PCR Machines, Sequencers, Luminometers
  • 9.8. Global Transplant Diagnostics Market, Sub-Segmentation Of Software And Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Data Analysis Software, Laboratory Information Management Systems (LIMS), Consulting Services, Technical Support And Maintenance Services

10. Transplant Diagnostics Market Regional And Country Analysis

  • 10.1. Global Transplant Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Transplant Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Transplant Diagnostics Market

  • 11.1. Asia-Pacific Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Transplant Diagnostics Market

  • 12.1. China Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Transplant Diagnostics Market

  • 13.1. India Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Transplant Diagnostics Market

  • 14.1. Japan Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Transplant Diagnostics Market

  • 15.1. Australia Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Transplant Diagnostics Market

  • 16.1. Indonesia Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Transplant Diagnostics Market

  • 17.1. South Korea Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Transplant Diagnostics Market

  • 18.1. Taiwan Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Transplant Diagnostics Market

  • 19.1. South East Asia Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Transplant Diagnostics Market

  • 20.1. Western Europe Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Transplant Diagnostics Market

  • 21.1. UK Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Transplant Diagnostics Market

  • 22.1. Germany Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Transplant Diagnostics Market

  • 23.1. France Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Transplant Diagnostics Market

  • 24.1. Italy Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Transplant Diagnostics Market

  • 25.1. Spain Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Transplant Diagnostics Market

  • 26.1. Eastern Europe Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Transplant Diagnostics Market

  • 27.1. Russia Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Transplant Diagnostics Market

  • 28.1. North America Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Transplant Diagnostics Market

  • 29.1. USA Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Transplant Diagnostics Market

  • 30.1. Canada Transplant Diagnostics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Transplant Diagnostics Market

  • 31.1. South America Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Transplant Diagnostics Market

  • 32.1. Brazil Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Transplant Diagnostics Market

  • 33.1. Middle East Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Transplant Diagnostics Market

  • 34.1. Africa Transplant Diagnostics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Transplant Diagnostics Market, Segmentation By Type, Segmentation By Transplant Type, Segmentation By Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Transplant Diagnostics Market Regulatory and Investment Landscape

36. Transplant Diagnostics Market Competitive Landscape And Company Profiles

  • 36.1. Transplant Diagnostics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Transplant Diagnostics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Transplant Diagnostics Market Company Profiles
    • 36.3.1. F. Hoffmann La-Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Becton-Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Hologic Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Transplant Diagnostics Market Other Major And Innovative Companies

  • Illumina Inc., BioMerieus S.A, Biomerieux SA, Grafton Companies, Bio-Rad Laboratories Inc., Sigma-Aldrich Corporation, Qiagen N.V., Immucor Transplant Diagnostics Inc., Immucor Inc., Luminex Corporation, Affymetrix Inc., CareDx Company, One Lambda Inc., Eurobio Scientific Group, Gendx BV

38. Global Transplant Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Transplant Diagnostics Market

40. Transplant Diagnostics Market High Potential Countries, Segments and Strategies

  • 40.1 Transplant Diagnostics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Transplant Diagnostics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Transplant Diagnostics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer